A step further for Sopharma’s Tabex in the US
Smoking cessation drug Tabex US rights holder Achieve Life Sciences closes merger with OngoGenex Pharmaceuticals, according to a regulatory filing by the latter. Cytisine has been an established treatment produced and marketed in Central and Eastern Europe by Sopharma for 15+ years under the brand of Tabex. The road of Tabex to US Leading generic… Read more
bg